Drug Type Hematopoietic stem cell therapy |
Synonyms Platelets produced in vitro from proplatelets derived from peripheral blood, XJ-PLT 001, XJ-PLT001 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationOrphan Drug (United States) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Congenital Amegakaryocytic Thrombocytopenia | Preclinical | United States | 28 Jul 2025 | |
Bernard-Soulier Syndrome | Preclinical | United States | 25 Apr 2025 |